ACF PHARMACEUTICALS is a pre-clinical stage company testing novel molecules targeting the PGE2 pathway, which is important in cancer, fibrosis, inflammation and pain, in a unique partnership with a private chemical company and a research institution.
IN THE NEWS
Houston Business Journal, December 2015
Xconomy, September 2015
BioNewsTexas, September 2015
Houston Business Journal, September 2015